Low Molecular Weight Heparin in Hemodialysis Patients with a Bleeding Tendency

Publisher： Karger

E-ISSN： 2235-3186|86|4|499-501

ISSN： 1660-8151

Source： Nephron, Vol.86, Iss.4, 2000-12, pp. : 499-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Use of Low-Molecular-Weight Heparin in Hemodialysis Patients: A 7-Year Experience

By  

Blood Purification, Vol. 27, Iss. 3, 2009-02 ,pp. : 242-245

Karger

Access to resources Recommend Favorite

Low Molecular Weight Heparin Reduces Triglyceride, VLDL and Cholesterol/HDL Levels in Hyperlipidemic Diabetic Patients on Hemodialysis

By  

American Journal of Nephrology, Vol. 18, Iss. 5, 1998-09 ,pp. : 384-390

Karger

Access to resources Recommend Favorite

Treatment of Pulmonary Embolism by Subcutaneous Low-Molecular- Weight Heparin in a Hemodialysis Patient

By  

American Journal of Nephrology, Vol. 18, Iss. 4, 1998-06 ,pp. : 325-328

Karger

Access to resources Recommend Favorite

Effects of Ultrapure Hemodialysis and Low Molecular Weight Heparin on the Endothelial Surface Layer

By  

Blood Purification, Vol. 38, Iss. 3-4, 2014-12 ,pp. : 203-210

Karger

Access to resources Recommend Favorite

Anaphylactoid Reaction Induced by Low-Molecular-Weight Heparin in a Hemodialysis Patient

By  

Nephron, Vol. 87, Iss. 1, 2001-01 ,pp. : 93-94

Karger

Access to resources Recommend Favorite